2-Chloro-6-(piperazin-1-yl)pyrazine

Catalog No. :
ACKTWM107
CAS No. :
64022-27-1
Molecular Formula :
C8H11ClN4
Molecular Weight :
198.66

IUPAC Name:2-chloro-6-(piperazin-1-yl)pyrazine

2-Chloro-6-(piperazin-1-yl)pyrazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$67.00Login to see priceInquiryInquiry
250mg95%$100.00Login to see priceInquiryInquiry
1g95%$168.00Login to see priceInquiryInquiry
5g95%$416.00Login to see priceInquiryInquiry
10g95%$700.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-6-(piperazin-1-yl)pyrazine
IUPAC Name2-chloro-6-(piperazin-1-yl)pyrazine
Molecular FormulaC8H11ClN4
Molecular Weight198.66
SMILESClC1=NC(N2CCNCC2)=CN=C1
InChI KeyCJAWPFJGFFNXQI-UHFFFAOYSA-N
SynonymMK 212 HYDROCHLORIDE;6-CHLORO-2-(1-PIPERAZINYL)PYRAZINE HYDROCHLORIDE;6-CHLORO-2-(1-PIPERAZINYL)PYRAZINE;MK212HCl;MK 212;2-CHLORO-6-(PIPERAZIN-1-YL)PYRAZINE, MK212;2-Chloro-6-(1-piperazinyl)pyrazine;2-Chloro-6-(Piperazin-1-Yl)Pyrazine
CAS No.64022-27-1
PubChem CID107992

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H317-H319
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACKTWM107 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. ACOHLT304 route compound structure diagram
    ACOHLT3044774-14-5 In Stock
  4. Then
  5. ACKTWM107 route product structure diagram
    ACKTWM10764022-27-1
Inquiry

2. ACKTWM107 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. ACAGNO847 route compound structure diagram
    ACAGNO847916791-07-6 In Stock
  4. Then
  5. ACKTWM107 route product structure diagram
    ACKTWM10764022-27-1
Inquiry

Comments (0)